Autolus Therapeutics
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
Key facts
| AngelList URL | https://angel.co/company/autolus |
|---|---|
| Legal Name | Autolus Therapeutics plc |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/autolus-limited |
| Full Address | 191 Wood Lane White City London W12 7FP |
| Legal Entity Identifier | 549300C0KZP8EYROLL02 |
| LinkedIn URL | https://www.linkedin.com/company/autolus-ltd-/about/ |
| Previous Name | Autolus Therapeutics Ltd |
| Stock Symbol | AUTL |
| Official Website | https://autolus.com |
| Wellfound ID | autolus |
| Wikidata ID | Q56583577 |
Contact details
Email and phone for Autolus Therapeutics are available to signed-in members of PharmaLyt.
Sign in to view